Correction: Evaluation of the initial timing of infection control pharmacist-driven audit and monitoring of vancomycin therapy in patients with infectious diseases: A retrospective observational study

Key Points

• The aim is to assess how the timing of infection control pharmacists' involvement affects vancomycin therapy in infectious disease cases.
• Conducted a retrospective observational study
• Evaluated records of patients receiving vancomycin
• Assessed the timing of pharmacist-driven audits and monitoring
• Findings indicate varying outcomes based on timing of pharmacist involvement
• Early audit showed potential for better patient outcomes
• Monitoring practices need optimization for effectiveness